{"database": "lobbying", "table": "lobbying_activities", "rows": [[2463030, "53e5cd54-a05e-4a99-a4a9-fed934e2b5e9", "Q2", "RUBICON ADVISORS, LLC", 315091, "AVET PHARMACEUTICALS", 2020, "second_quarter", "PHA", "GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES", 30000, null, 0, 0, "2020-07-09T13:54:47.707000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2463030"], "units": {}, "query_ms": 12.135026045143604, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}